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Exhaled breath condensate (EBC) is being used increasingly to sample airway fluid. EBC pH
may be a biomarker of airway inflammation in asthma. In this study, we assessed the long-
term reproducibility of EBC pH in asthma. We examined 31 asthmatic patients and eight
healthy subjects three times over a 1-year period (winter, autumn and summer). EBC pH
was measured after argon deaeration. Repeatability of pH measurements was assessed
using intraclass correlation coefficients (ICC) and the limits of agreement (LOA) between
seasons were calculated according to Bland–Altman method.
No significant differences in EBC pH between seasons were detected in healthy subjects
and asthmatic patients. EBC pH showed high repeatability either in healthy subjects
(ICC ¼ 0.94) or in asthmatics (ICC ¼ 0.97). Variability between seasons was greater in
asthmatics than in healthy subjects: winter–autumn LOA 0.68/+0.52 and 0.31/+0.31,
autumn–summer LOA 0.75/+0.67 and 0.24/+0.15, winter–summer LOA 0.92/+0.67
and 0.34/+0.23 in asthmatic and healthy subjects, respectively. In a subgroup of 11
asthmatics who remained in stable conditions during the study, no substantially different
LOA were observed in EBC pH compared with the whole group of asthmatics. Asthmatic
smokers (n ¼ 10) tended to have lower EBC pH (7.5770.46) than asthmatic non-smokers
(n ¼ 21) (7.7470.21; p ¼ 0.063) and wider LOA.
In conclusion, we demonstrated that EBC pH exhibits good repeatability in long-term
assessment. EBC pH in asthmatics tended to fluctuate more than in healthy subjects.
However, EBC pH variability in asthma was not influenced by changes in clinical status.
Rather, we suggest that cigarette smoke may be implicated in EBC pH variability.
& 2007 Elsevier Ltd. All rights reserved.Elsevier Ltd. All rights reserved.
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Exhaled breath condensate (EBC) is a biological fluid that is
collected by cooling exhaled air during tidal breathing.
Collection of EBC is a non-invasive, simple and inexpensive
method that can be performed repeatedly without adversely
affecting a patient. EBC pH is currently considered a robust
variable to determine the degree of acidification of EBC in
patients with various inflammatory lung diseases. An
abnormally low EBC pH is found during acute exacerbations
of asthma, chronic obstructive pulmonary disease (COPD)
and cystic fibrosis, and also in stable COPD, bronchiectasis
and moderate asthma.1–3 It is still controversial whether
EBC pH correlates with other indices of airway inflamma-
tion.4,5 However, this simple assay might be a useful
surrogate for invasive or more complicated attempts at
assessment of airway inflammation in asthma, such as
biopsy, bronchoalveolar lavage or induced sputum. Technical
confounders that may affect pH measurements have been
investigated in order to refine this tool for application in
clinical setting.6–8
Short-term repeatability of measuring EBC pH in asth-
matic and healthy subjects was evaluated by some
studies.5,6,8,9 However, studies on long-term variability of
airway pH have not been performed. This information may
be relevant for the use of EBC pH as biomarker in longer
prospective studies.
The aim of this study was to assess the long-term
repeatability of EBC pH in asthma. EBC was collected in a
standardized manner in healthy subjects and stable asth-
matics three times over 1-year period and pH was measured
in Argon-deaerated samples.
Methods
Subjects
A total of 32 patients with mild to severe asthma, diagnosed
according to the Global initiative for Asthma (GINA),10 and
10 healthy volunteers were recruited for the study.
Subjects were excluded if they had experienced an
exacerbation of asthma or respiratory tract infection within
the last 4 weeks. All subjects provided written informed
consent and the local ethics committee approved the study.
Collection of EBC and pH measurement
EBC was collected with a simple homemade apparatus as
described by Goldoni et al.11 Samples were collected during
tidal breathing for 15min. Subjects were instructed to
breathe normally through their mouth and to temporarily
discontinue collection if they needed to swallow saliva or
cough. No food was taken 1 h before collection. Samples
were stored in 200 ml aliquots and Argon gas was bubbled in
the sample for 3min to achieve deaeration. In preliminary
experiments, we found that pH increases bubbling argon up
to 2min; then, deaeration for 4, 8, and 10min did not
induced further changes in pH. Therefore, we established
that bubbling argon for 3min is sufficient for optimal
deaereation of 200 ml EBC samples. Then, pH was measured
using a calibrated pH meter (model pH300; Hanna Instru-ments, Padova, Italy) with a flat membrane electrode (5207;
Crison Instruments S.A., Alella, Spain) and an accuracy of
70.01 pH.
Amylase was measured in all samples using an enzymatic
colorimetric test (IFCC; Roche Diagnostic Modular, lower
limit of detection 3U/L). Samples containing amylase were
discarded.Effects of the temperature and the duration of
collection on EBC pH
The effect of temperature and duration of collection on EBC
pH were evaluated in samples of 10 healthy subjects.
Consecutive collections at various temperatures (5, 20,
and 55 1C) were performed. To evaluate the effect of
duration of collection on pH, EBC was collected at 5-min
consecutive intervals for a total time of 20min. All samples
were processed for pH assay after deaeration with argon.Long-term repeatability of EBC pH
Long-term repeatability of EBC pH was tested in asthmatic
and healthy subjects. Samples of EBC for pH analysis were
collected on three occasions over a year period (winter,
autumn and summer). On each occasion, EBC was collected
for 15min at a condenser temperature of 55 1C. The level
of asthma control was evaluated at each visit with lung
function tests (forced expiratory volume in 1 s, FEV1),
asthma control questionnaire (ACT),12 regimen of inhaled
and/or oral corticosteroids.Statistical analysis
Comparisons of sampling conditions (different temperatures
and duration of collection), among seasons, between
asthmatic and healthy subjects, and between smokers
and non-smokers were performed by repeated measures
analysis of variance. Values of po0.05 were considered
significant.
Intraclass correlation coefficients (ICC) were deter-
mined13 and Bland–Altman analysis14 was performed for pH
measured on three occasions over a year to evaluate
repeatability. The limits of agreement (LOA) were calcu-
lated to estimate the variability expected from individual
measurements. Data are presented as mean7SD.Results
Subjects
Table 1 shows the characteristics of the subjects examined.
The two groups of subjects were similar with regard to age
and sex. Two healthy subjects were lost to follow-up and one
asthmatic patient was excluded due to exacerbation. Thus,
8 healthy subjects and 31 asthmatics completed the study
on long-term repeatability. Mean FEV1/FVC of the asthmatic
group was 92714%. One patient with severe asthma was on
oral corticosteroids.
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breath condensate
Mean values (7SD) of EBC pH collected at condenser
temperatures of 5, 20, 55 1C and at collection intervals
of 5, 10, 15, and 20min are presented in Table 2. There were
no significant differences identified in the pH of EBC
collected at different temperatures in these healthy
subjects. Furthermore, the duration of collection did not
significantly affect EBC pH values.
Long-term repeatability of EBC pH
No significant differences in EBC pH among seasons were
detected in healthy subjects (winter 7.8870.08, autumn
7.8970.14, summer 7.8470.10; p ¼ 0.56) and asthmatic
patients (winter 7.7570.37, autumn 7.6770.20, summer
7.6370.36; p ¼ 0.34). Asthmatics tended to exhibit lower
EBC pH than healthy subjects, but the difference was not
significant (p ¼ 0.23). We did not find any relationship of
EBC pH with gender, smoked pack-year, or grade of severity
of asthma.
EBC pH showed high repeatability either in healthy
subjects (ICC ¼ 0.94) or in asthmatics (ICC ¼ 0.97). We then
asked whether pH variability was related to changes in the
level of asthma control assessed by different parameters
during the study. Changes in FEV1 by more than 20%, in ACT
score by more than 1 point, in dose of daily corticosteroids
by 50% or more among the three visits were used to
define subgroups of patients with a lower control of asthma.Table 1 Characteristics of healthy subjects and asth-
matic patients.
Healthy
subjects
Asthmatic
patients
Subjects (no., sex) 3M, 7F 16M, 16F
Age (mean7SD) 3571 3977.6
Severity of asthma
(GINA 2006)
– 7 mild (22%)
11 moderate
(34%)
14 severe
(44%)
Inhaled steroids (no., %) – 22 (69%)
Oral steroids (no., %) – 1 (3%)
Current smokers (no., %) 1(10%) 10 (31%)
Pack-year (no.) – 15713
Table 2 Effects of temperature and duration of collection on
Temperature of collection (1C) pH (mean7SD)
5 7.7270.38
20 7.5770.58
55 7.9170.73
ANOVA p ¼ 0.36Table 3 shows ICC in subgroups of asthmatics defined
according to these criteria. Patients with higher FEV1
variability tended to have slightly less ICC of EBC pH, while
ACT score and dosage of corticosteroids did not affect pH
repeatability.
Variability between seasons was greater in asthmatics
than in healthy subjects: winter–autumn LOA 0.68/+0.52
and 0.31/+0.31, autumn–summer LOA 0.75/+0.67 and
0.24/+0.15, winter–summer LOA 0.92/+0.67 and 0.34/
+0.23 in asthmatic and healthy subjects, respectively
(Figure 1a, b). The LOA were calculated in a subgroup of
11 asthmatic patients who were defined in stable conditions
along the period of the study, i.e. exhibiting changes in
FEV1o20%, in ACT score o2 points, and in daily dose of
corticosteroids o50%. Except for autumn–summer LOA
(0.28/+0.44), no substantially different LOA were ob-
served in winter–summer (0.86/+0.72) and winter–autumn
(0.76/+0.59) EBC pH compared with the whole group of
asthmatics. We further investigated whether EBC pH
variability was affected by smoking habit. EBC pH tended
to be lower in asthmatic smokers (7.5770.46) than in
asthmatic non-smokers (7.7470.21), but the difference
was not statistically significant (p ¼ 0.063). The LOA were
wider in asthmatic smokers than in asthmatic non-smokers
(Figure 2a, b).
Discussion
In this study, we have demonstrated that measurements of
EBC pH exhibit high repeatability in asthmatics and healthyEBC pH.
Duration of collection (min) pH (mean7SD)
5 7.3570.88
10 7.4370.68
15 7.5270.48
20 7.5770.49
p ¼ 0.10
Table 3 Intraclass correlation coefficients (ICC) of EBC
pH in subgroups of asthmatic patients defined by variability
of FEV1, ACT score, daily dose of corticosteroids.
Parameter No. of patients ICC
Change in FEV1
a
420% 10 0.92
p20% 21 0.98
Change in ACT scorea
X2 14 0.98
o2 17 0.95
Change in corticosteroids dosea
X50% 16 0.96
o50% 15 0.98
aCalculated as maximal change among the three visits.
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Figure 1 Limits of agreement for long-term variability of
exhaled breath condensate pH in asthmatic patients (a) and
healthy control subjects (b).
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Figure 2 Limits of agreement for long-term variability of
exhaled breath condensate pH in asthmatic smokers (a) and
asthmatic non-smokers (b).
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EBC pH were observed in asthmatics over time suggesting
that airway pH fluctuated in this disease. In addition, we
confirmed, using a different collection apparatus, that pH in
deaerated EBC is not influenced by the temperature of the
condenser.8 The trend of increased pH when the duration of
collection was increased, although not statistically signifi-
cant, suggests that the period of condensation should be
kept constant to obtain comparable results.Although the temperature we used to condensate the
exhaled breath was lower than in some previous studies, the
mean EBC pH values in healthy subjects of current study is
consistent with that observed in a large data set collected to
obtain normative data for EBC pH.15 Since EBC pH value is
dependent on the collection device used, our result not
necessarily can be extended to EBC pH collected with
commercial devices.16 Asthmatic patients tended to have
lower EBC pH than healthy subjects, but the difference was
not significant. This is in agreement with the findings of recent
studies in adults and children with atopic stable asthma.4,17 A
further reason for the lack of significant difference between
asthmatic and healthy subjects is that the majority of our
asthmatic patients were using inhaled corticosteroids. In fact,
the study by Hunt et al.3 found that therapy with glucocorti-
costeroids increased the EBC pH in asthmatic subjects towards
the values measured in normal subjects.
Other studies assessed repeatability of EBC pH, but in
none a long-term follow-up of asthmatic patients was
applied. This is relevant because information of long-term
repeatability is necessary to design and interpret prospec-
tive studies in asthma when EBC pH is used as a non-invasive
marker of airway biochemistry. Vaughan et al.8 reported a
good repeatability of deaerated EBC pH using a commercial
apparatus. Intra-week coefficient of variation (CV) was 4.5%
(range 0.9–20%) in 76 healthy subjects. A similar intra-week
CV of pH measured in not deaerated EBC collected with a
different device in a group of subjects including 26 healthy
controls and 42 asthmatics (CV 5.0%, range 1.8–8.1%) was
obtained by Prince et al.9 The coefficients of variation
calculated for longer term measurements of EBC pH in our
asthmatic (2.4%, range 0.6–10.6%) and healthy subjects
(1.2%, range 0.8–1.6%) were less than intra-week CVs
previously reported. Kostikas et al.1 assessed the repeat-
ability of EBC pH on 2 consecutive days in normal subjects
and patients with asthma and COPD. However, the data
were presented as means and the variability between
individual samples cannot be estimated.
Between day LOA for pH of samples collected maximum 1
week apart reported by Leung et al.5 (0.32/0.31) and by
Borrill et al.6 (0.46/0.44) in healthy controls were not
narrower than those between seasons in the present study.
This suggests that in normal subjects EBC pH is relatively
stable and there are not additional sources of variation in
the long-term period.
Although asthma exhibits more clinical and functional
variability than COPD, between-day variability of EBC pH
was much higher in COPD6 than in our patients with asthma.
The reason by which EBC pH fluctuates more in COPD
remains undetermined since the mechanisms of airway pH
regulation are poorly understood. It can be hypothesized
that oxidative stress and/or bacterial colonization may
contribute to variations of pH in COPD.18,1
We examined whether clinical status, functional para-
meters and drug treatment can explain EBC pH variability.
Changes in ACT score, in FEV1 and in the corticosteroids
regimen were not associated with higher variability. In
addition, the measurements of EBC pH in asthmatics who
remain in stable conditions during the study visits were not
more repeatable than those in less stable patients. There-
fore, the source of pH variability in asthma remains
undetermined.
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inhaled particles and gases, temperature and humidity may
influence EBC pH variability. This possibility could explain
why less agreement was observed both in stable asthma
and healthy controls between EBC pH measurements in
winter samples and those performed in the other seasons,
than between measurements in autumn and summer.
Average concentrations of air-suspended particulate matter
(PM10) in the urban area of Padova, where the patients
lived, was indeed higher in winter at the time when the
patients were examined (84.6729.3 mg/m3) than in summer
(43.8712.9 mg/m3, po0.001) or autumn (47.2714.0 mg/m3,
po0.001). Similarly, the other pollutants derived from
combustion (SO2, NO2, CO) were significantly higher in
winter compared with the other seasons (data not shown).
Variability of EBC pH due to smoking was not investigated
previously in asthma. Vaughan et al.8 stated that being a
cigarette smoker did not appear to affect EBC pH in healthy
subjects and similar variability was observed in COPD ex-
smokers and current smokers.6 Since our aim was to
investigate whether smoking influences pH variability, not
if EBC pH values are different in smoking and non-smoking
asthmatics, the study is possibly not powered for this
comparison. Indeed, we calculated that 16 subjects for
group are necessary to show a difference in EBC pH of 0.3
with a significance of 0.05 and a power of 80% assuming a SD
of 0.3, as observed in the present study. Our findings that
smoking habit increases EBC pH variability is in line with the
hypothesis that environmental factors may affect EBC.
In conclusion, we demonstrated that EBC pH exhibits good
repeatability even in long-term assessment. EBC pH in
asthmatics tended to fluctuate more than in healthy
subjects. However, EBC pH variability was not influenced
by changes in clinical, functional and therapeutical para-
meters in asthma. Rather, we suggest that environmental
factors may be implicated in EBC pH variability. The
significance of EBC pH has been challenged, at least in
COPD, by Effros et al.19 Since the present study was not
designed to compare controlled and not controlled asth-
matics and subjects under exacerbation were not examined,
our results leave open the question whether EBC pH is
sufficiently sensitive to detect changes in clinical and
functional status of asthma milder than those during an
exacerbation. Therefore, the clinical utility of longitudinal
monitoring of EBC pH remains to be determined.
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